Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/ams2.72 http://scihub22266oqcxt.onion/10.1002/ams2.72 29123703/?report=reader!5667212!29123703     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Acute+Med+Surg 2015 ; 2 (2): 114-116 Nephropedia Template TP {{tp|p=29123703|t=2015. Calcium channel blocker attenuated opioid withdrawal syndrome |pdf=|usr=}}{{29123703}} gab.com Text Calcium channel blocker attenuated opioid withdrawal syndrome JO: Acute Med Surg http://www.kidney.de/pget.php?&tw=1&pmid=29123703 #FOAvip CASE: A 61-year-old woman was diagnosed with deep cervical abscess and enlarged mediastinal abscess. These required a protracted period of mechanical ventilation and neck and thoracic drainage surgery with daily wound lavage, necessitating the administration of large amounts of fentanyl and dexmedetomidine. After extubation, fentanyl was discontinued but dexmedetomidine was continued, and she developed hypertension, tachycardia, tachypnea, and hyperthermia within several hours; therefore, she was diagnosed with opioid withdrawal syndrome. Her symptoms failed to improve with either an increased dexmedetomidine dose or a diltiazem infusion for symptomatic management. Ultimately, 20 mg nifedipine was given through a nasogastric tube, which led to a resolution of withdrawal symptoms. OUTCOME: This is the first case of calcium channel blockers attenuating opioid withdrawal syndrome symptoms in a human. CONCLUSION: Calcium channel blockers might be alternative therapy to refractory opioid withdrawal syndrome. Case accumulation in the future is expected. Twit Text FOAVip Calcium channel blocker attenuated opioid withdrawal syndrome ????Acute Med Surg http://www.kidney.de/pget.php?&tw=1&pmid=29123703 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=29123703 #FOAvip English Wikipedia <ref>{{Cite pmid|29123703}}</ref> Calcium channel blocker attenuated opioid withdrawal syndrome #MMPMID29123703 Shimatani T; Adachi H; Mihashi H; Usumoto N; Yoshimoto K; Ayukawa K Acute Med Surg 2015[Apr]; 2 (2): 114-116 PMID29123703show ga CASE: A 61-year-old woman was diagnosed with deep cervical abscess and enlarged mediastinal abscess. These required a protracted period of mechanical ventilation and neck and thoracic drainage surgery with daily wound lavage, necessitating the administration of large amounts of fentanyl and dexmedetomidine. After extubation, fentanyl was discontinued but dexmedetomidine was continued, and she developed hypertension, tachycardia, tachypnea, and hyperthermia within several hours; therefore, she was diagnosed with opioid withdrawal syndrome. Her symptoms failed to improve with either an increased dexmedetomidine dose or a diltiazem infusion for symptomatic management. Ultimately, 20 mg nifedipine was given through a nasogastric tube, which led to a resolution of withdrawal symptoms. OUTCOME: This is the first case of calcium channel blockers attenuating opioid withdrawal syndrome symptoms in a human. CONCLUSION: Calcium channel blockers might be alternative therapy to refractory opioid withdrawal syndrome. Case accumulation in the future is expected. äCalcium channel blocker attenuated opioid withdrawal syndrome (epmc).pdf DeepDyve Pubget Overpricing